{"url_path":"/sec/alt/8-k/2026-06-16/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1326190/0001104659-26-074575-index.html","accession_number":"0001104659-26-074575","cik":"0001326190","ticker":"ALT","issuer_name":"Altimmune, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1326190/0001104659-26-074575-index.html","primary_entity_key":"0001326190","primary_entity_name":"Altimmune, Inc."},"word_count":524,"has_tables":true,"body_markdown":"**Item 8.01 Other Events.**\n\n \n\nOn June 16, 2026, Altimmune,\nInc. (the “Company”) announced plans to relocate its corporate headquarters from Gaithersburg, Maryland to Morristown, New\nJersey later this year. The new headquarters is in a geography with a strong presence of biopharmaceutical companies, which is expected\nto support the Company’s ability to attract top-tier talent in its hybrid business model, as the Company continues its growth as\na late-stage development company.\n\n \n\nThe Company has entered into an office lease agreement for the New\nJersey headquarters where the Company will make rent payments of approximately $300,000 annually for the 5-year lease term.  The\nmove of the headquarters is expected to help the company achieve cost efficiencies over the long term.\n\n \n\n**Cautionary Note Regarding Forward Looking Statements**\n\n \n\nThis Current Report on Form 8-K and certain of the materials\nfiled herewith contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as\namended, including, without limitation, statements regarding the Offering and anticipated closing, and expectations regarding our\ncash runway, use of capital, expenses and other future financial results. The words “may,” “might,”\n“will,” “could,” “would,” “should,” “expect,” “plan,”\n“anticipate,” “intend,” “believe,” “expect,” “estimate,”\n“seek,” “predict,” “future,” “project,” “potential,”\n“continue,” “target” and similar words or expressions are intended to identify forward-looking statements,\nalthough not all forward-looking statements contain these identifying words. Any forward-looking statements, such as those related\nto the anticipated plan to relocate the Company’s headquarters, the anticipated timing of the relocation, the potential of the\nnew location to assist in attracting talent, the continued growth of the company and any potential cost efficiencies created by the\nmove, are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ\nmaterially from those expressed or implied by any forward-looking statements contained in this Current Report on Form 8-K. These\nstatements are based on management's current expectations and are not predictions of actual performance. These forward-looking\nstatements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor\nas a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are\ndifficult or impossible to predict and will differ from assumptions. These and other risks and uncertainties are described in\ngreater detail in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year\nended December 31, 2025 and any subsequent filings with the Securities and Exchange Commission. In addition, any forward-looking\nstatements represent the Company’s views only as of today and should not be relied upon as representing its views as of any\nsubsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements. No representations or\nwarranties (expressed or implied) are made about the accuracy of any such forward-looking statements.\n\n \n\n \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange\nAct of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**ALTIMMUNE, INC.**\n\n \n \n \n\n \nBy:\n/s/ Gregory Weaver\n\n \n \nName: Gregory Weaver\n\n \n \nTitle: Chief Financial Officer\n\n \n\nDated: June 16, 2026"}